The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

EWTX FINANCIAL STATEMENTS

Edgewise Therapeutics Inc — balance sheet, income statement and cash flow trends

EWTXEdgewise Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-200 M-100 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue0 $Gross Profit-590 K $ · -Infinity%Operating Income-218.9 M $ · -Infinity%Pre-tax Income-197.2 M $ · -Infinity%Net Income to Owners-197.2 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $-100.0%
Gross Profit-590 K $—
Operating Income-218.9 M $—
EBITDA-197.2 M $—
Net Income to Owners-197.2 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M600 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets479.7 M
  • Equity448.1 M $93%
  • Current Liabilities29 M $6%
  • Long-term Liabilities2.6 M $1%

Key Figures

YoY change
Total Assets479.7 M $-21.8%
Total Liabilities31.6 M $+30.3%
Total Equity448.1 M $-23.9%
Cash & ST Investments460.7 M $-22.4%
Total Debt3.6 M $-17.9%
Net Debt-68.7 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-150 M-100 M-50 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-150 M-100 M-50 M0-159.4 M $Operating166.4 M $Investing8.7 M $Financing15.7 M $Net Change

Key Figures

YoY change
Operating Cash Flow-159.4 M $—
Capital Expenditures564 K $-36.5%
Free Cash Flow-159.6 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on EWTX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.